MY184297A - Water soluble pharmaceutical film with enhanced stability - Google Patents

Water soluble pharmaceutical film with enhanced stability

Info

Publication number
MY184297A
MY184297A MYPI2016701359A MYPI2016701359A MY184297A MY 184297 A MY184297 A MY 184297A MY PI2016701359 A MYPI2016701359 A MY PI2016701359A MY PI2016701359 A MYPI2016701359 A MY PI2016701359A MY 184297 A MY184297 A MY 184297A
Authority
MY
Malaysia
Prior art keywords
film
moisture
curving
sticky
melt
Prior art date
Application number
MYPI2016701359A
Inventor
Anwar Siraj Daud
Nidhi Prakash Sapkal
Minal Nandkumar Bonde
Original Assignee
Zim Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zim Laboratories Ltd filed Critical Zim Laboratories Ltd
Publication of MY184297A publication Critical patent/MY184297A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

This invention comprises an Oral Thin Film that is instantly wettable, rapid dissolving, non-sticky, non-tacky and non-curving, the said Film capable of carrying an active ingredient for oral delivery being a moisture stabilized film that remains non-sticky and non-curving when exposed to 70?5 % RH (Relative Humidity) at 25?C for at least 2 minutes up to 2 hours in open conditions without packaging.; and a process/method of making them. The active ingredient may comprise, without limitation, an active pharmaceutical, nutraceutical or cosmaceutical ingredient. The processes/method comprising (a) drying a casted film in two or more stages, (b) drying of the film after casting is done alternately both the sides, (c) coating the dried film with synthetic water insoluble moisture resistant/moisture repellant hydrophobic polymers that does not melt at high temperature, (d) adding a synthetic water insoluble moisture resistant/moisture repellant hydrophobic polymer that does not melt at high temperature to the solution to be casted as a film.
MYPI2016701359A 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability MY184297A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IN2014/000652 WO2015083181A2 (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
IN3221MU2013 IN2013MU03221A (en) 2013-10-14 2014-10-13

Publications (1)

Publication Number Publication Date
MY184297A true MY184297A (en) 2021-03-31

Family

ID=53274239

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016701359A MY184297A (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability

Country Status (8)

Country Link
BR (1) BR112016008356B1 (en)
CA (1) CA2927334C (en)
CL (1) CL2016000880A1 (en)
EA (1) EA038558B1 (en)
IN (1) IN2013MU03221A (en)
MY (1) MY184297A (en)
UA (1) UA123893C2 (en)
WO (1) WO2015083181A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10660862B2 (en) * 2013-12-17 2020-05-26 Zim Laboratories Limited Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
KR20190128637A (en) * 2017-03-30 2019-11-18 인텔젠스 코프. Therapeutic Methods and Apparatus for Improved Bioavailability of Leukotriene Receptor Antagonists
FR3082851B1 (en) * 2018-06-25 2022-09-02 Biomerieux Sa METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5947987B2 (en) * 1979-10-08 1984-11-22 富士写真フイルム株式会社 Matsuto film that can be added/edited
US4664859A (en) * 1983-12-02 1987-05-12 Vcf Films Inc. Div. Of Pmc Process for solvent casting a film
US5272191A (en) * 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
US6966960B2 (en) * 2003-05-07 2005-11-22 Hewlett-Packard Development Company, L.P. Fusible water-soluble films for fabricating three-dimensional objects
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
KR100705210B1 (en) * 2004-09-23 2007-04-06 주식회사 한독약품 Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus
US20090162516A1 (en) * 2007-12-21 2009-06-25 Brown Solomon E Edible, water-soluble film

Also Published As

Publication number Publication date
WO2015083181A3 (en) 2015-12-03
EA201690751A1 (en) 2016-08-31
UA123893C2 (en) 2021-06-23
BR112016008356A2 (en) 2017-08-01
EA038558B1 (en) 2021-09-14
CA2927334A1 (en) 2015-06-11
BR112016008356B1 (en) 2022-12-13
CL2016000880A1 (en) 2017-01-27
CA2927334C (en) 2023-08-29
WO2015083181A2 (en) 2015-06-11
IN2013MU03221A (en) 2015-07-03

Similar Documents

Publication Publication Date Title
CY1120492T1 (en) A DRUG RELEASE FORMAT
BR112018073703A2 (en) skin or wound patch, pharmaceutical composition and method for the release of an active substance
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
ECSP17046608A (en) PHARMACEUTICAL FORM INCLUDING A SOLID AMORPHOUS DRUG SOLUTION
AR063468A1 (en) PHARMACEUTICAL COMPOSITIONS
IL299897B1 (en) Multi-unit drug delivery devices and methods
WO2010042798A3 (en) Modified silk films containing glycerol
MX356111B (en) Immediate release, abuse deterrent pharmaceutical compositions.
MX2018005206A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site.
MY184297A (en) Water soluble pharmaceutical film with enhanced stability
CY1122114T1 (en) N-ACETYLOCYSTEINE SWALLOWED TABLETS
WO2015107544A3 (en) Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
WO2013013038A3 (en) Doping agents and polymeric compositions thereof for controlled drug delivery
PH12015502556A1 (en) Modified release formulation
CY1123202T1 (en) CONTROLLED RELEASE HYDROCORTISONE FORMULATION
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
BR112017002719A2 (en) lactide block copolymer and preparation method
EA201390979A1 (en) COMPOSITIONS OF BENZIMIDAZOLES WITH MODIFIED SURVIVAL
PH12016500693B1 (en) Slow-release solid oral compositions
BR112015010243A2 (en) solid dispersion, oral administration composition, pharmaceutical composition, and method for preparing a solid dispersion
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
WO2012055947A3 (en) Preparation of orodispersible films
EA201001245A1 (en) CONTAINING ESTRADIOL SYSTEM OF DELIVERY OF MEDICINES
JP2013249283A5 (en)
Naik et al. Formulation and evaluation of esomeprazole magnesium dihydrate multiple unit particulate system (pellets) as a delayed release dosage form.